Astley-Sparke Philip 4
4 · Replimune Group, Inc. · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
Replimune (REPL) Director Philip Astley‑Sparke Sells Shares
What Happened
- Philip Astley‑Sparke, a director of Replimune Group, sold 17,657 shares of REPL on May 18, 2026. The filing reports aggregate proceeds of $89,698. The reported per‑share price is shown as $5.08; the filer notes a weighted average sale price ranged from $5.02 to $5.08.
Key Details
- Transaction date: 2026-05-18; Form 4 filed 2026-05-20 (appears timely).
- Reported shares sold: 17,657; reported proceeds: $89,698.
- Price details: weighted average price between $5.02 and $5.08; filing lists $5.08.
- Footnote: Sale was a "sell to cover" to satisfy tax withholding for partial vesting of RSUs and was not a discretionary sale by the reporting person (F1).
- Filing does not disclose shares owned by the reporting person after the transaction in the provided excerpt.
Context
- This was a tax‑withholding sale tied to RSU vesting (a routine administrative transaction), not an open-market discretionary sell motivated by investment views. Such "sell to cover" transactions are common when restricted stock units vest and taxes are due.
Insider Transaction Report
Form 4
Astley-Sparke Philip
Director
Transactions
- Sale
Common Stock
[F1][F2]2026-05-18$5.08/sh−17,657$89,698→ 1,412,414 total
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $5.02 to $5.08 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range.
Signature
/s/ Shawn Glidden, attorney-in-fact|2026-05-20